Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Reducing Prevalence of Addiction Begins with Youth Prevention: One Choice for Health (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the RyeACT: a model for how a health-oriented prevention message can impact youth, families and local communities from The ASAM 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Nearly all adults with substance use disorders began using addictive substances as teens, most commonly with alcohol, nicotine and marijuana. The adolescent brain is hardwired for risk-taking putting teens at the highest risk for problems related to substance use including addiction. Reducing the risk of future substance use problems, including addiction, begins with prevention of youth drug use. Physicians caring for young patients are in a uniquely important position to provide health-focused drug prevention messages both to youth and to their families, including the recommendations laid out by the American Academy of Pediatrics (AAP) for screening, brief intervention and referral to treatment (SBIRT) with the health goal of no use of any substance by youth under 21. This workshop presents data from two major national surveys of teen substance use behaviors and it involves the audience in a discussion of how physicians can engage directly with youth to address the public health crisis posed by substance use and addiction. These data show youth drug use (and non-use) are closely related and that the percentage of youth making the decision not to use any drug has been steadily increasing for nearly four decades. In 2015 26% of American high school students had never used any alcohol, cigarettes, marijuana or other drugs in their lifetimes and 51% had not used any in the prior 30 days. Supported by these data, this workshop will present a straightforward and clear prevention message for youth under age 21. One Choice: Do not use any alcohol, nicotine, marijuana or other drugs for reasons of health. This workshop will highlight the experience of RyeACT, a coalition that has comprehensively integrated the One Choice prevention message into the local community. RyeACT is a model for how a health-oriented prevention message can impact youth, families and local communities. The role of physicians treating teens and young adults in integrating this message will be emphasized.


    Learning Objectives:

    1.) Articulate the brain science of the vulnerability of the adolescent brain to substance use. 
    2.) Describe how the One Choice message fits into the SBIRT recommendations of the American Academy of Pediatrics.
    3.) Apply the experiences of the RyeACT Coalition with the One Choice to medicine and integrate into future physician interactions with young patients and their families.


    Caroline DuPont

    MD

    Caroline DuPont, MD is Vice President of the non-profit Institute for Behavior and Health. In this role she focuses on the areas of addiction treatment and prevention. Dr. DuPont maintains a private practice specializing in anxiety and addiction. She received her MD from the University of Texas Health Sciences Center, Houston and completed her training at the Johns Hopkins Hospital, Baltimore, where for years she held an appointment on the clinical faculty of psychiatry. She is board certified by the American Board of Psychiatry and Neurology and by the American Board of Addiction Medicine. As President and Principal Investigator of DuPont Clinical Research, she directed a team of researchers that conducted studies of investigational medication for the anxiety and affective disorders. She is the co-author of numerous publications and several books on anxiety and addiction.

    Robert L. DuPont

    MD, DFASAM

    For more than 40 years, Robert L. DuPont, M.D. has been a leader in drug abuse prevention and treatment. He served as the first Director of the National Institute on Drug Abuse (1973-1978) and as the second White House Drug Chief (1973-1977). From 1968-1970 he was Director of Community Services for the District of Columbia Department of Corrections, heading parole and half-way house services. From 1970-1973, he served as Administrator of the District of Columbia Narcotics Treatment Administration. Following this distinguished public career, in 1978 Dr. DuPont became the founding president of the Institute for Behavior and Health, Inc., a non-profit organization that identifies and promotes new ideas to reduce illegal drug use. He has been Clinical Professor of Psychiatry at the Georgetown University School of Medicine since 1980. 

    A graduate of Emory University, Dr. DuPont received an M.D. degree in 1963 from the Harvard Medical School. He completed his psychiatric training at Harvard and the National Institutes of Health in Bethesda, Maryland. 

    Dr. DuPont is a Life Fellow of the American Society of Addiction Medicine. His activities in ASAM include chairing the forensic science committee from 1995 to 2004, and serving as Co-Chair of the two White Paper writing committees that produced The Role of the Physician in “Medical” Marijuana in 2010 and State-Level Proposals to Legalize Marijuana in 2012. He served as Chair of the writing committee that produced Drug Testing: A White Paper of the American Society of Addiction Medicine in 2013. He is also a Life Fellow of the American Psychiatric Association and was chairman of the Drug Dependence Section of the World Psychiatric Association from 1974 to 1979. In 1989 he became a founding member of the Medical Review Officer Committee of ASAM."

    Nancy Pasquale

    Nancy Pasquale is the Co-founder and Coalition Coordinator of RyeACT, a substance abuse prevention coalition in Rye, New York. Ms. Pasquale's professional background is in human resources development/curriculum design. She spent a decade  volunteering in the Rye schools. As a PTO Co-President, Ms. Pasquale sourced and organized cultural and academic enrichment activities and advocated on educational policy at the local and state level. She spent three years as Co-President of the Friends of the Rye City School District and was recognized for her leadership in mobilizing voters to pass a $17M facilities bond. Ms. Pasquale served two three-year terms as an elected Trustee of the Rye City School District Board of Education. As Trustee, she chaired or served on committees including: Curriculum Council, Professional Development, Facilities, Policy, and Health and Safety. Drawing on insight she gained through years of community service to youth, Ms. Pasquale co-founded RyeACT in 2014 and built the organization’s infrastructure. Leveraging her deep connection to the community, she garnered support for the coalition’s mission and that connection continues to motivate and inform Ms. Pasquale’s work. In 2016, she co-authored the grant proposal that secured $625,000 in federal funding through the Drug Free Communities program of the ONDCP. As Coalition Coordinator, Ms. Pasquale oversees all programmatic aspects of the Coalition. She serves as Co-Adviser of the RyeACT Youth Action Team, working directly with youth leaders on peer-to-peer initiatives. Under Ms. Pasquale’s stewardship, RyeACT has been recognized for exemplary leadership in youth  prevention.  The coalition was one of seventeen to be admitted to the national pilot cohort of CADCA’s Graduate Coalition Academy and Ms. Pasquale has presented at CADCA’s National Leadership Forum (2017,2018,2019). She is pleased to join the Institute of Behavior and Health to present at the American Society of Addiction Medicine conference (April, 2019). 

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Policy Plenary Session (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about approaches taken by state Medicaid programs to combat the opioid overdose crisis from The ASAM 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    State Medicaid programs play a vital role in financing and facilitating access to treatment for substance use disorder for individuals with limited income and resources. In 2014 alone, the federal/state insurance program financed over 20% of all addiction treatment. Across the country, states have worked to transform their Medicaid programs as a response to changes in federal and state laws, and new funding and waiver opportunities. This plenary session will explore a cross section of approaches taken by state Medicaid programs to equip attendees with an understanding of the intersection between state, federal, and insurance policies used to combat the opioid overdose crisis.




    Beth Kidder

    MPP

    Ms. Kidder is the Deputy Secretary for Medicaid at Florida’s Agency for Health Care Administration. She has served in state Medicaid programs for twenty years and has led Florida’s Medicaid program since 2017. Florida Medicaid provides health and long-term care services to almost four million low income Floridians primarily through a managed care delivery system. Ms. Kidder was instrumental in transforming the state’s Medicaid program to a managed care model and reorganizing the state’s business processes to support this change. Her expertise is in managed care, long-term care services, coverage policies, quality improvement, and organizational development. Ms. Kidder holds a Bachelor’s degree from the University of Florida and a Master of Public Policy from Duke University.  

    Jennifer S. Lee

    MD

    Jennifer Lee, MD, serves as the Director of the Department of Medical Assistance Services, the Virginia state Medicaid agency, responsible for overseeing a $10 billion budget and providing health coverage for over 1 million Virginians. Previously she served as Deputy under Secretary for Health for Policy and Services and Senior Advisor to the Secretary at the U.S. Department of Veterans Affairs. There she was responsible for overseeing national policy and leading key initiatives for the Nation’s largest integrated health care system, with over 1,200 sites of care serving more than nine million veterans. From 2014-16, Dr. Lee served as Deputy Secretary of Health and Human Resources for Governor Terry McAuliffe. She helped launch his “A Healthy Virginia” plan to improve access to care for people with mental illness and address the opioid crisis through innovative Medicaid waivers and programs, led the Governor’s bioscience initiative, and spearheaded new employment opportunities for former combat medics and corpsmen. From 2008-11, she served on the Virginia Board of Medicine. Dr. Lee has also served as a White House Fellow, a health policy fellow on the U.S. Senate Health, Education, Labor, and Pensions Committee, and a Policy Research Scholar and Associate Professor at George Washington University. She received her bachelor’s in biophysics and biochemistry from Yale University, her medical degree from Washington University School of Medicine, and completed her residency at Johns Hopkins. She is a board-certified, practicing emergency physician and a fellow of the American College of Emergency Physicians. 

    Kimberly Brandt

    JD, MA

    Kimberly Brandt is the Principal Deputy Administrator at the Centers for Medicare and Medicaid Services.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Leading and Presenting to Large Group Audiences (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning how to develop effective interactive and collaborative teaching skills from The ASAM 50th Annual Conference (2019).

    (1 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    The faculty in this interactive session will present brief “tips” on leading and teaching to large groups, through brief didactic presentations, each of which will be followed by group discussion and an opportunity for participants to ask questions.  The topics will focus on developing effective interactive and collaborative teaching skills, including creating an interactive learning environment, leading large group discussions, gaining and maintaining audience attention through effective presentation style and slides, incorporating audio-visual examples into presentations, and managing group dynamics.  The session format will allow the faculty to model these same tips in action.  Special attention will be given to the use of case-based learning strategies, adapting presentations for diverse audiences, the use of reflection and audience-polling strategies to encourage interaction.  Participants will have opportunities to ask questions of the faculty during the session.  The session will conclude with a review of how the session presented the tips in action.  

    Learning Objectives: 

    1.) Lead large group discussions using case-based learning strategies and visual stimuli as examples
    2.) Engage audiences in active participation through  strategies such as polling, pair and share, and reflection
    3.) Adapt presentation strategies to diverse inter-professional audiences


    Peter Selby

    MBBS, CCFP, FCFP, DFASAM

    Peter Selby MD is the Director of Medical Education and a Clinician Scientist at the Centre for Addiction and Mental Health. He is a Professor in the Departments of Family and Community Medicine, Psychiatry, and the Dalla Lana School of Public Health at the University of Toronto. He is also a Clinician Scientist in the Department of Family and Community Medicine. Dr. Selby is the Executive Director and creator of the TEACH project; a continuing education certificate program in Applied Counselling for Health with a focus on smoking cessation, through the University of Toronto. Dr. Selby' research, as a Principal Investigator at the Ontario Tobacco Research Unit, includes smoking cessation especially in smokers with co-morbid conditions. As the Principal Investigator of the STOP Study, he investigates the effectiveness of NRT and counselling in different types of intervention settings. He is also the PI of CANADAPTT- a unique Canadian Smoking Cessation Guideline development and dissemination project. Dr. Selby also continues his clinical research with pregnant women who use substances and is the PI of a knowledge translation program (PREGNETS) to increase the adoption of evidence-based interventions with pregnant smokers. 

    He has received grant funding totaling over 80 million dollars from CIHR, NIH, and Ministry of Health and has published 130 peer reviewed publications. He has published 5 books (including 4 edited), is the author of 30 book chapters, and 32 research reports prepared for the government. He is the Co-Chair for the Ministry of Health Cessation Task force and the Chair of the Canadian Centre on Substance Abuse National Task Force on Treatment for Prescription Drug Misuse. Dr. Selby mentors Fellows in Addiction Medicine and Addiction Psychiatry, junior investigators and medical students. Dr. Selby a sought after speaker for various topics including addictive disorders, motivational interviewing, and health behavior change.

    Miriam Komaromy

    , MD, FACP,DFASAM

    Dr. Miriam Komaromy is a physician and professor of medicine at the University of New Mexico in the United States.  She is board certified in Internal Medicine and Addiction Medicine.  She has been an Associate Director in the ECHO Institute, leading ECHO programs that are focused on treatment of substance use disorders for the past 13 years.  She consults with programs around the world on implementation of the ECHO model to expand access to specialized medical care, and particularly focuses on ECHO for addictions, mental health, care of complex populations, and ECHO programs to support community health workers. Dr. Komaromy provides clinical consultation and outpatient care for patients with complex substance use disorders.  She has served as Medical Director for New Mexico’s addiction treatment hospital, and led the development of the state’s guidelines for treatment of opioid use disorder.  Dr. Komaromy is a member of the board of directors of the American Society of Addiction Medicine (ASAM), which is the largest addiction-specialty society in the United States.  She is vice-chair of ASAM’s national medical education committee, and she chairs their Fundamentals of addiction medicine committee.  She was recently elected ASAM educator of the year for 2019.  Dr. Komaromy lectures nationally and internationally on addiction medicine topics, including treatment of opioid use disorder, harm reduction, and how to address the use of amphetamine-type substances.  Dr. Komaromy is currently serving as a Fulbright Scholar in Hanoi, Vietnam, performing research and providing education on treatment of substance use disorders.


    Michael Fingerhood

    MD, FACP

    Dr. Michael Fingerhood is an Associate Professor of Medicine at the Johns Hopkins University. He is the Chief of the Division of Chemical Dependence and medical director of the Comprehensive Care Practice (CCP) at Johns Hopkins Bayview Medical Center. The CCP integrates substance abuse treatment with primary medical care, including care for HIV and hepatitis C.

    Catherine Friedman

    MD

    Catherine R. Friedman, MD is a consulting psychiatrist in the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH), and Medical Director for the Rhode Island Department of Children, Youth and Families (DCYF). She is also an Assistant Professor (Clinical) at Warren Alpert Brown Medical School.  She has board certifications in Addiction Medicine, Child and Adolescent Psychiatry, and General Psychiatry. She has worked extensively with children, adolescents, and families affected by substance use disorder. Dr. Friedman received a bachelor’s degree from the University of Michigan, did graduate work at The Rockefeller University in New York, and earned her medical degree from Harvard Medical School.  She completed an internship in obstetrics, gynecology and reproductive sciences at the University of California San Francisco. She trained in psychiatry at the Western Psychiatric Institute and Clinics, University of Pittsburgh Medical Center where she completed a residency in general adult psychiatry and a fellowship in child and adolescent psychiatry.   At BHDDH, Dr. Friedman is involved with research, education, and provision of treatmentment for co-occuring psychiatric disorders throughout the state of Rhode Island. She is actively involved in resident and fellow education for Psychiatry and Addiction Medicine trainees at Brown. She is Chair of American Society of Addiction Medicine's CME committee and on that group's Medical Education Council. Her specific research and clinical interests include identification and treatment of co-occurring disorders and substance use disorders in adults and adolescents, addiction as a family disease, gender differences in co-occurring disorders, and perinatal addictions.  She has lectured in multiple settings, from local to international, on these and related topics and also published in these areas.

    Daniel P. Alford

    MD, MPH, FACP, DFASAM

    Dr. Daniel P. Alford is an Associate Professor of Medicine, Assistant Dean of CME and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine. He is a diplomate in Addiction Medicine by the American Board of Addiction Medicine (ABAM).

    He is director of the Clinical Addiction Research and Education Unit medical director of the Office-Based Opioid Treatment (OBOT) program and of the Massachusetts Screening, Brief Intervention, Referral to Treatment Training and Technical Assistance (MASBIRT TTA) program and former program director for the Addiction Medicine Fellowship program at Boston Medical Center (BMC). Since 2001 he has served as the course director of the Chief Resident Immersion Training (CRIT) Program in Addiction Medicine: Improving Clinical and Teaching Skills for Generalists funded by NIDA. He is president of the Association for Medical Education and Research in Substance Abuse (AMERSA). In 2011, he was recognized as a Champion of Change by the White House. In 2014 he received the Health Education Award from the American Medical Association.

    Marcia Jackson

    PhD

    Dr. Marcia Jackson is President of CME by Design, a consulting group that provides the full range of instructional design services in the field of continuing medical education. Dr. Jackson served as division vice president and senior advisor for education at the American College of Cardiology from 1992-2007. She is a past President of the Alliance for Continuing Medical Education, a past member of the National Task Force on CME Provider/Industry Collaboration, and current chair of the Medscape Education Advisory Board, She is a recipient of the ACCME Robert Razskowski Award and the Alliance for CME Distinguished Service Award.  She has been an ASAM consultant since 2013.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Leading Small Group Learning Activities (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning how to develop effective interactive and collaborative teaching skills when working with small groups The ASAM 50th Annual Conference (2019).

    (1 CME) In this conference recording from the 2019 Annual Conference, you will learn:


    The faculty in this interactive session will present brief “tips” in didactic format, each of which will be followed by small group discussion and an opportunity for participants to ask questions.  The topics will focus on developing effective interactive and collaborative teaching skills when working with small groups, including creating an interactive learning environment through the use of strategies such as polling, leading small group discussions, incorporating simulation and role-play into small group learning activities, and creating worksheets for use to guide small group discussions.  Special attention will be given to managing group dynamics so as to maintain participant focus and address varied types of participant interruptions.  The session design will illustrate 1/3 x 3 activity design, i.e., tell, show, do). The session format will allow the faculty to model these same tips in action.  The session will conclude with a review of how the session presented the tips in action.  


    Learning Objectives: 

    1.) Lead small group discussions using case-based strategies, simulations, modeling, and role-play
    2.) Develop worksheets to guide small group discussions and support learning activities
    3.) Adapt presentation strategies to diverse inter-professional audiences


    Peter Selby

    MBBS, CCFP, FCFP, DFASAM

    Peter Selby MD is the Director of Medical Education and a Clinician Scientist at the Centre for Addiction and Mental Health. He is a Professor in the Departments of Family and Community Medicine, Psychiatry, and the Dalla Lana School of Public Health at the University of Toronto. He is also a Clinician Scientist in the Department of Family and Community Medicine. Dr. Selby is the Executive Director and creator of the TEACH project; a continuing education certificate program in Applied Counselling for Health with a focus on smoking cessation, through the University of Toronto. Dr. Selby' research, as a Principal Investigator at the Ontario Tobacco Research Unit, includes smoking cessation especially in smokers with co-morbid conditions. As the Principal Investigator of the STOP Study, he investigates the effectiveness of NRT and counselling in different types of intervention settings. He is also the PI of CANADAPTT- a unique Canadian Smoking Cessation Guideline development and dissemination project. Dr. Selby also continues his clinical research with pregnant women who use substances and is the PI of a knowledge translation program (PREGNETS) to increase the adoption of evidence-based interventions with pregnant smokers. 

    He has received grant funding totaling over 80 million dollars from CIHR, NIH, and Ministry of Health and has published 130 peer reviewed publications. He has published 5 books (including 4 edited), is the author of 30 book chapters, and 32 research reports prepared for the government. He is the Co-Chair for the Ministry of Health Cessation Task force and the Chair of the Canadian Centre on Substance Abuse National Task Force on Treatment for Prescription Drug Misuse. Dr. Selby mentors Fellows in Addiction Medicine and Addiction Psychiatry, junior investigators and medical students. Dr. Selby a sought after speaker for various topics including addictive disorders, motivational interviewing, and health behavior change.

    Miriam Komaromy

    , MD, FACP,DFASAM

    Dr. Miriam Komaromy is a physician and professor of medicine at the University of New Mexico in the United States.  She is board certified in Internal Medicine and Addiction Medicine.  She has been an Associate Director in the ECHO Institute, leading ECHO programs that are focused on treatment of substance use disorders for the past 13 years.  She consults with programs around the world on implementation of the ECHO model to expand access to specialized medical care, and particularly focuses on ECHO for addictions, mental health, care of complex populations, and ECHO programs to support community health workers. Dr. Komaromy provides clinical consultation and outpatient care for patients with complex substance use disorders.  She has served as Medical Director for New Mexico’s addiction treatment hospital, and led the development of the state’s guidelines for treatment of opioid use disorder.  Dr. Komaromy is a member of the board of directors of the American Society of Addiction Medicine (ASAM), which is the largest addiction-specialty society in the United States.  She is vice-chair of ASAM’s national medical education committee, and she chairs their Fundamentals of addiction medicine committee.  She was recently elected ASAM educator of the year for 2019.  Dr. Komaromy lectures nationally and internationally on addiction medicine topics, including treatment of opioid use disorder, harm reduction, and how to address the use of amphetamine-type substances.  Dr. Komaromy is currently serving as a Fulbright Scholar in Hanoi, Vietnam, performing research and providing education on treatment of substance use disorders.


    Catherine Friedman

    MD

    Catherine R. Friedman, MD is a consulting psychiatrist in the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities and Hospitals (BHDDH), and Medical Director for the Rhode Island Department of Children, Youth and Families (DCYF). She is also an Assistant Professor (Clinical) at Warren Alpert Brown Medical School.  She has board certifications in Addiction Medicine, Child and Adolescent Psychiatry, and General Psychiatry. She has worked extensively with children, adolescents, and families affected by substance use disorder. Dr. Friedman received a bachelor’s degree from the University of Michigan, did graduate work at The Rockefeller University in New York, and earned her medical degree from Harvard Medical School.  She completed an internship in obstetrics, gynecology and reproductive sciences at the University of California San Francisco. She trained in psychiatry at the Western Psychiatric Institute and Clinics, University of Pittsburgh Medical Center where she completed a residency in general adult psychiatry and a fellowship in child and adolescent psychiatry.   At BHDDH, Dr. Friedman is involved with research, education, and provision of treatmentment for co-occuring psychiatric disorders throughout the state of Rhode Island. She is actively involved in resident and fellow education for Psychiatry and Addiction Medicine trainees at Brown. She is Chair of American Society of Addiction Medicine's CME committee and on that group's Medical Education Council. Her specific research and clinical interests include identification and treatment of co-occurring disorders and substance use disorders in adults and adolescents, addiction as a family disease, gender differences in co-occurring disorders, and perinatal addictions.  She has lectured in multiple settings, from local to international, on these and related topics and also published in these areas.

    Michael Fingerhood

    MD, FACP

    Dr. Michael Fingerhood is an Associate Professor of Medicine at the Johns Hopkins University. He is the Chief of the Division of Chemical Dependence and medical director of the Comprehensive Care Practice (CCP) at Johns Hopkins Bayview Medical Center. The CCP integrates substance abuse treatment with primary medical care, including care for HIV and hepatitis C.

    Daniel P. Alford

    MD, MPH, FACP, DFASAM

    Dr. Daniel P. Alford is an Associate Professor of Medicine, Assistant Dean of CME and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine. He is a diplomate in Addiction Medicine by the American Board of Addiction Medicine (ABAM).

    He is director of the Clinical Addiction Research and Education Unit medical director of the Office-Based Opioid Treatment (OBOT) program and of the Massachusetts Screening, Brief Intervention, Referral to Treatment Training and Technical Assistance (MASBIRT TTA) program and former program director for the Addiction Medicine Fellowship program at Boston Medical Center (BMC). Since 2001 he has served as the course director of the Chief Resident Immersion Training (CRIT) Program in Addiction Medicine: Improving Clinical and Teaching Skills for Generalists funded by NIDA. He is president of the Association for Medical Education and Research in Substance Abuse (AMERSA). In 2011, he was recognized as a Champion of Change by the White House. In 2014 he received the Health Education Award from the American Medical Association.

    Marcia Jackson

    PhD

    Dr. Marcia Jackson is President of CME by Design, a consulting group that provides the full range of instructional design services in the field of continuing medical education. Dr. Jackson served as division vice president and senior advisor for education at the American College of Cardiology from 1992-2007. She is a past President of the Alliance for Continuing Medical Education, a past member of the National Task Force on CME Provider/Industry Collaboration, and current chair of the Medscape Education Advisory Board, She is a recipient of the ACCME Robert Razskowski Award and the Alliance for CME Distinguished Service Award.  She has been an ASAM consultant since 2013.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Annual Review of Addiction Medicine: Highest Impact Publications for 2018-2019 (1.5 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the most important research and scholarly developments in the addiction field from The ASAM 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    This focus session is a recurring annual review of the highest impact peer-reviewed publications or newsmaker events across the field of Addiction Medicine for 2018-2019. The goal of this session is to provide the learner with a concise, structured, and critical summary of the most important research and scholarly developments in the field. The review is organized by ASAM Principles of Addiction Medicine Chapters: neurobiology, epidemiology, pharmacology, intoxication and withdrawal syndromes, screening and diagnosis, mutual help, harm reduction, criminal justice, dual diagnoses, and pharmacologic and behavioral interventions. Articles from 2018-2019 are evaluated and ranked by objective publication metrics (journal Impact Factor, most downloaded and viewed statistics, and Altmetric scores), expert opinion, and for representation across all Principles chapter headings.  Example articles and events from 2018: Alcohol use and burden for 195 countries and territories, 1990�"2016 (The Lancet); Medication for opioid use disorder after nonfatal opioid overdose and association with mortality (Annals of Internal Medicine); Postincarceration fatal overdoses after implementing medications for addiction treatment (JAMA Psychiatry); Major NIAAA study of moderate drinking shut down (NYTimes); Weekly and monthly subcutaneous buprenorphine depot formulations (JAMA Internal Medicine); RETRACTED - The impact of medically supervised injection centers on drug-related harms (Intl J Drug Policy).   

    Learning Objectives:

    1.) Review the latest Addiction Medicine research's impact on patient care.
    2.) Adapt this ASAM presentation and slide deck as open-access teaching material. 
    3.) Assess the impact of recent research studies on opioid and other addiction health policy. 



    Joshua D. Lee

    MD, MSc, FASAM

    Joshua D. Lee MD, MSc is an Associate Professor in the Departments of Population Health and Medicine at the NYU School of Medicine. He is board-certified in Internal Medicine and Addiction Medicine and is a physician at Bellevue Hospital Center, NYU Langone Medical Center, and in the NYC jails. He directs the NYU ABAM Fellowship in Addiction Medicine. His research focuses on novel and medication treatments for addiction among criminal justice and primary care populations.

    Sarah Wakeman

    MD, FASAM

    Sarah E. Wakeman, MD is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative, program director of the Mass General Addiction Medicine fellowship, and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team, co-chair of the Mass General Opioid Task Force, and clinical lead of the Partners Healthcare Substance Use Disorder Initiative. She is the Medical Director of RIZE Massachusetts, a state-wide, private sector initiative created to build a $50 million fund to implement and evaluate innovative interventions to address the opioid overdose crisis. She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and fellow of the American Board of Addiction Medicine. She is chair of the policy committee for the Massachusetts Society of Addiction Medicine. She served on Massachusetts' Governor Baker’s Opioid Addiction Working Group. Nationally, she is chair of the American Society of Addiction Medicine Drug Court Task Force and serves on their ethics committee.Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her research interests include evaluating models for integrated substance use disorder treatment in medical settings, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Implementing OUD treatment at Community Health Centers: Challenges and Solutions (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about best practices and different models of office based opioid treatment from The ASAM 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Learning Objectives:

    The growing opioid epidemic has appropriately led to calls for primary care providers to offer medication for addiction treatment (MAT) in office-based settings.  Federal and state funding opportunities have allowed Community Health Centers (CHCs) - safety net health centers- to introduce or expand existing MAT services.  However, many CHC systems are new to addiction medicine and to MAT, and few have the opportunity to meet with individuals from other systems to discuss challenges and potential solutions in developing an effective evidence-based program.  As a follow up to the popular 2018 ASAM conference session, this session will connect community health center providers with peers to share challenges and best practices. The session organizers will open the session by discussing different models of office based opioid treatment.  They will also describe the challenges they see many health systems struggle with when initiating a new office-based MAT program and describe solutions that they’ve seen effectively executed.  The second half of the session will be spent in small groups that will discuss challenges in implementing  integrated MAT into existing CHC programming.  Topics will include stigma, staffing, addressing patients’ psychosocial needs, and working with patients who continue to use drugs. Group members will work together to share their own experiences and discuss potential solutions. The session organizers have relevant experiences that position them well to lead this workshop. Dr. Rachel King is the Medical Director of the CHC OBAT Training and Technical Assistance at Boston Medical Center, and has implemented an Opioid Project ECHO geared at CHC teams, in addition to her work as a primary care physician at South End Community Health Center. Dr. Elizabeth Salisbury-Afshar developed the Chicago MAT Learning Collaborative, which brought ten Chicago-based CHCs together to learn from one another and share best practices.  Elizabeth also created and implemented an integrated MAT program at Heartland Health Outreach, a Chicago CHC that serves people experiencing homelessness and living with HIV. Amanda Brooks is a social worker and the Chief Population Health Officer at PCC Community Wellness Center, a Chicago FQHC located in the epicenter of the City’s opioid epidemic.  Amanda developed and implemented PCC’s Chemical Dependency Programming, and was a co-lead and faculty member for the Chicago MAT Learning Collaborative with Dr. Salisbury-Afshar.  
    1.) Upon completion, participants will be able to describe different MAT delivery models in CHC settings and address challenges of implementation. 
    2.) Upon completion, participants will be able to identify ways to address team based care in an integrated MAT program.
    3.) Upon completion, participants will be able to describe linkage models that support recovery processes across delivery systems.  



    Elizabeth M. Salisbury-Afshar

    MD, MPH, FAAFP, FASAM, FACPM

    Elizabeth Salisbury-Afshar, MD, MPH serves as the Medical Director of Behavioral Health for the Chicago Department of Public Health and is an Assistant Professor in the Departments of Family Medicine and Psychiatry, Section of Population and Behavioral Health, at Rush University Medical Center. She is certified in family medicine, addiction medicine and preventive medicine/general public health. Elizabeth previously served as Medical Director of Behavioral Health Systems Baltimore- a quasi-public entity that oversees all publicly funded addiction and mental health treatment in Baltimore City. In this role, she helped develop and implement the Baltimore City Overdose Prevention Plan. Elizabeth came back to Chicago in 2014 and served as Medical Director of Heartland Health Outreach (HHO), a federally qualified health center and healthcare for the homeless provider (330H) in Chicago. While at HHO, she expanded their addiction treatment services and developed a medication assisted treatment program. 

    Elizabeth has been working with the Chicago Department of Public Health since September of 2016 and continues to volunteer seeing patients in the medication assisted treatment program at HHO. In her role with the City Health Department, she guides the Department's work in the area of substance use as it relates to data analysis, policy, programming initiatives, and funding allocation.

    Rachel Beth King

    MD FASAM

    Rachel King MD FASAM, works as a primary care physician and addiction specialist at the South End Community Health Center and Boston Medical Center, where she advocates for the treatment of substance use disorders in the primary care setting.  She serves as the medical director of Boston Medical Center's Opioid ProjectECHO, a videoconferencing educational series aimed at primary care teams to improve care of patients with substance use disorders.  She is also the medical director of the HCRC Jamaica Plain methadone OTP program. 

    Amanda Brooks

    LCSW, CADC

    Amanda Brooks, Licensed Clinical Social Worker and Certified Alcohol and Drug Counselor, is the Chief Population Health Officer at PCC Community Wellness Center and is responsible for the following programs: Behavioral Healthcare, Care Coordination, Illinois Breast and Cervical Cancer, and PCC Urban Farm.  Since 2011, Amanda has developed and implemented the Chemical Dependency Program for the treatment of substance use disorders, predominantly opioid dependence, resulting in PCC’s first integrated direct access Medication Assisted Treatment clinic.  In 2017, Amanda supported the implementation of Chicago's first integrated outpatient prenatal and substance abuse treatment program for women with opioid use disorder.  Additionally, as an awardee of both the HRSA Behavioral Health Service Expansion Grant and Substance Abuse Expansion Grant, Amanda facilitated the implementation of telehealth and SBIRT.  Amanda is a collaborator and content contributor to the Chicago Department of Public Health Medication Assisted Treatment (MAT) Learning Collaborative.  Additionally, Amanda also continues to provide direct patient care.  Amanda is a graduate of the University of Chicago School of Social Service Administration.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Pain is Inevitable, Misery is Optional: Emotion Regulation Skills in Pain Treatment (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about emotional regulation skills used in the chronic and acute pain population for a more comprehensive treatment approach from The ASAM 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Recently there has been research and a better understanding of the interactions among, biological, psychological and social factors that affect health and illness.  This has led to a paradigm shift from a biomedical reductionism approach to a more comprehensive biopsychosocial model.  This interaction is apparent in working with chronic and acute pain patients where mental health, addiction and medical pathologies prominently interface.  Research has shown that this combination in pain disorders creates challenges in self-regulation and increases the possibility of acquiring a substance use disorder and/or addiction.  Emotion regulation skills play a vital role in working through the challenges this population will encounter for better outcomes, acceptance of the pain disorder and its accompanying emotional and mental concerns and teaching patient’s self-regulation skills to effectively work through the pain without depending primarily on opiate prescriptions.  This presentation focuses on effective emotion regulation skills used in the chronic and acute pain population for a more comprehensive treatment approach.  These skills affectively target and help manage mental health conditions, addiction and related behavioral difficulties, distressing emotions and physical pain symptoms while increasing successful outcomes.  


    Learning Objectives:

    1.) Understand the biospychosocial model and the importance of behavioral health in chronic and acute pain treatment
    2.) Describe emotion regulation skills used with chronic/acute and dually diagnosed patients
    3.) Practice a sampling of successful emotion regulation skills



    Osvaldo Cabral

    MA, LPC, LAC

    Osvaldo “Ozzie” Cabral has worked in addiction and mental health since 2002.  His areas of expertise include Addiction Treatment, Dialectical Behavior Therapy, Skills Training, Schema-Focused Therapy, working with the chronically mentally ill and treating dually diagnosed clients. Additional areas of specialization include Aggression Replacement Training, Cognitive Behavioral Therapy, Pain Treatment and Trauma-Focused Therapies. As Director of Integrated Services, he coordinates the operations of New Health’s medical and behavioral health professionals to ensure continuity of care for New Health patients.  Ozzie also co-founded and operates “Song of the Wolf Healing Center” which is a wolf and wolf-dog rescue in Bailey, Colorado.

    Bari Platter

    MS, RN, PMHCNS-BC

    Bari Platter is a Clinical Nurse Specialist at the University of Colorado Hospital

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Keys to Building Successful Fellowship Training Programs (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning how to help contribute to the growth of the fellowship workforce from the 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    In less than a decade, Addiction Medicine fellowship programs have established themselves as central to the discipline’s emergence and expansion as the newest formally recognized medical subspecialty. The number of physicians in these training programs has grown steadily, and they are proving their value in patient care, medical education, and health system leadership. Nevertheless, the majority of medical schools and teaching hospitals still do not have fellowships, and additional programs are needed to meet the critical shortage of addiction medicine workforce. This workshop will provide valuable insights for those who wish to lead or play a role in responding to this need. The expert panel includes experienced fellowship program directors who also have leadership positions in the American College of Academic Addiction Medicine (the new successor organization to The Addiction Medicine Foundation and the Addiction Medicine Fellowship Directors Association). In the first part of the workshop, the panelists will take participants through the fellowship development process based on their own experiences with issues including funding strategies, faculty recruitment and clinical rotation design. Each panelist represents a different primary specialty (Family Medicine, Internal Medicine, Pediatrics and Psychiatry), giving participants a unique opportunity to compare fellowship design options in this multispecialty subspecialty. The second part of the workshop will feature breakout groups in which participants will work with an application form from the Accreditation Council for Graduate Medical Education (ACGME). Under the guidance of the panelists, each group will complete one key part of the application (e.g., inpatient rotations, outpatient rotations, didactics and scholarly activities), then report out on their draft. The panel (whose members have also been involved in developing the ACGME requirements for Addiction Medicine) will then reassemble to offer comments on the drafts and suggestions for improvement. Ample time will be provided for questions and discussion, and all participants will be offered the opportunity for ongoing technical assistance.  


    Learning Objectives:

    1.) Describe the key requirements for accreditation of an Addiction Medicine fellowship training program.
    2.) Design a clinical rotation for teaching patient care competencies in Addiction Medicine.
    3.) Identify didactic activities for teaching medical knowledge competencies in Addiction Medicine.



    Lon R. Hays

    MD, MBA, DFAPA, DFASAM

    Lon Roberts Hays, M.D., M.B.A. graduated from medical school at the University of Kentucky in 1982 then pursued residency training at the University of Kentucky, which he completed in 1986. At that time he joined the faculty in the Department of Psychiatry where he has served as Chair from 1998 to 2018, and is director of the Addiction Medicine Fellowship.  In addition to being Board Certified by the American Board of Psychiatry and Neurology, Dr. Hays also is certified by the American Board of Addiction Medicine and has Added Qualifications in both Addiction Psychiatry and Geriatric Psychiatry. He completed a Certificate of Medical Management in 1998 and went on to obtain his M.B.A. from the University of Kentucky Gatton School of Business in May 2001.  Dr. Hays is a Co-investigator on numerous grants involving drugs of abuse.  He is the Director of Area V of the American Academy of Addiction Psychiatry, President of the Addiction MedicineFoundation, a Distinguished Fellow of the American Psychiatric Association, and an elected member and Fellow of the American College of Psychiatrists."

    Randall T. Brown

    MD, PhD, DFASAM

    Dr. Brown is Board Certified in Family Medicine and Addiction Medicine and has 17 years of clinical and teaching experience in these two specialty areas, as well as research training and applied, published research experience with a focus upon addiction health services research. He provides consultation for substance use disorders at Federally Qualified Health Centers (Access Community Health Centers), at 3 hospitals, and at the Univeristy of Wisconsin's HIV/AIDS Clinic in Madison, WI. He has completed fellowships in research methods (NRSA Primary Care Research Fellowship) and academic career development (Alcohol Medical Scholars Program, UCSF Faculty Development Fellowship). He also completed a doctoral dissertation in Population Health Sciences with a focus on Addiction Health Services Research with an additional certificate in Clinical Investigations. He is a Director of the American College of Academic Addiction Medicine (ACAAM) and the Chair of ACAAM's Fellowship Directors Committee. He is the founding director of 2 addiction medicine (ADM) fellowship programs at UW and at the Madison VA Medical Center. He co-authored ADM Fellowship Program Requirements for submission to the American Council on Graduate Medical Education. He is additionally experienced in leadership and collaboration on NIH, VA, SAMHSA, HRSA and other (intramural and private) funding awards. In the last 5 years, he has served as PI (10 awards) or co-investigator (7 awards) on 17 successful applications resulting in more than $14 million in funding, 22 peer-reviewed publications, and 35 abstracts accepted for regional and national presentations during that time. He has contributed extensively to other published efforts aiming to educate physicians in training on substance-related issues, including 7 book chapters, practice questions for the ADM Board Examination, and SAMHSA Treatment Improvement Protocols.

    Jeanette M. Tetrault

    MD, FACP, FASAM

    Dr. Tetrault’s scholarly work focuses on care of patients with addicition and the medical co-morbidities associated with substance use, mainly HIV and Hepatitis C. She is a diplomate of the American Board of Addiction Medicine. Dr. Tetrault is a physician providing primary care and buprenorphine/naloxone treatment at the Central Medical Unit of the APT Foundation, a multi-specialty addiction treatment facility, and is an attending physician at Yale New Haven Hospital (YNHH). She is the co-director of the Addiction Recovery Clinic in the Adult Primary Care Clinic at the St. Raphael's Campus of YNHH, which serves both a clinical care and a teaching mission. She was selected as a Macy Foundation Faculty Scholar in 2017. She is the Program Director for the Yale Addiction Medicine Fellowship Program and serves on the Board of Directors for The Addiction Medicine Foundation and the Addiction Medicine Fellowship Directors Association. She is a past-president of the New England Region of SGIM and co-chair of the Alcohol, Tobacco and Other Drug Use Interest Group for SGIM.

    Timothy K. Brennan

    MD, MPH, FASAM

    Timothy Brennan, MD, MPH, FASAM is an Addiction Medicine physician and Pediatrician. He is the Director of the Addiction Institute at Mount Sinai West and St. Luke's Hospitals in New York City and the Vice President for Medical and Academic Affairs at The Addiction Medicine Foundation. He is also the Director of the Fellowship in Addiction Medicine at the Icahn School of Medicine at Mount Sinai. He completed a Fellowship in Addiction Medicine at the Addiction Institute of New York, a Fellowship in Medical Ethics at Harvard Medical School, a Residency in Pediatrics at Weill Cornell Medical College / New York Presbyterian Hospital, and an Internship in Internal Medicine at Georgetown University Hospital. He is the Co-Editor of Essentials of Addiction Medicine and Board Certified in Addiction Medicine and Pediatrics.

    Andrew A. Danzo

    BA

    Andrew Danzo is Director of Fellowship Development for The American College of Academic Addiction Medicine (formerly The Addiction Medicine Foundation). He has been involved in developing fellowship training programs since 2010 as part of the successful effort to build a graduate medical education infrastructure for Addition Medicine and achieve its formal recognition by the American Board of Medical Specialties and the Accreditation Council for Graduate Medical Education. Based in the Department of Family Medicine at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Mr. Danzo has also worked on a variety of projects, including faculty development, the New York State Rural Health Research Center and New York State Area Health Education Center. From 2000-2009, he served as Associate Editor of The Journal of Rural Health. He earned a BA in economics and political science from Rutgers University and previously worked for a number of years as a journalist.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Becoming Certified in Addiction Medicine through ABPM (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the requirements and various pathways available for physicians to apply for eligibility to sit for the Addiction Medicine subspecialty exam from the 50th Annual Conference (2019).

    Starting in the spring of 2017, the American Board of Preventive Medicine (ABPM) began offering physicians who are certified by a Member Board of the American Board of Medical Specialties (ABMS) the opportunity to apply and become certified in the subspecialty of Addiction Medicine. Michael Weaver, MD, DFASAM, Addiction Medicine Subboard Chair, and Chris Ondrula, JD, Executive Director of ABPM, will review the requirements and various pathways, i.e., Practice Pathway and Fellowship, available for physicians to apply for eligibility to sit for the Addiction Medicine subspecialty exam. This includes a streamlined process for application for those who are already certified by the American Board of Addiction Medicine (ABAM). Information on the timeline for the 2019 application cycle, dates for the examination period, and fee schedule will also be made available.  Information will also be provided for attendees who are already certified in Addiction Medicine by ABPM about maintenance of certification (MOC). Ample time will be provided for questions from the attendees. For more information visit the ABPM booth in the exhibit hall or www.theabpm.org.  

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:


    Learning Objectives:

    1.) Identify the different pathways to certification in Addiction Medicine through ABPM.
    2.) Recognize requirements to be eligible for certification in Addiction Medicine through ABPM.
    3.) Discuss requirements and available options for maintenance of certification (MOC) in Addiction Medicine through ABPM.



    Michael F. Weaver

    MD, DFASAM

    Dr. Michael Weaver is Professor of Psychiatry and Medical Director of the Center for Neurobehavioral Research on Addiction at The University of Texas McGovern Medical School at Houston. He completed a Residency in Internal Medicine and a Clinical Research Fellowship in Addiction Medicine at Virginia Commonwealth University. He is involved in patient care, medical education, and research. Dr. Weaver has multiple publications in the field of addiction medicine. He treats patients at the Innovations Addiction Treatment Clinic at the Texas Medical Center in Houston, which provides medication-assisted treatment. He is the Sub-Board Chair for Addiction Medicine for the American Board of Preventive Medicine.  He is a member of the ASAM Publications Council and on the Editorial Board for the Journal of Addiction Medicine.

    Christopher Ondrula

    JD

    Christopher J. Ondrula, JD Executive Director of the American Board of Preventive Medicine Currently, Mr. Ondrula is the Executive Director for the American Board of Preventive Medicine (ABPM).  As Executive Director, Mr. Ondrula works with the ABPM Board of Directors to develop and operationalize overall ABPM strategic initiatives through the planning and coordination of projects designed to advance ABPM’s goals.  That work includes the creation and implementation of a key performance indicator report that contains operational metrics and outcome measures that quantify organizational productivity and provides a platform for improved operational performance.  Mr. Ondrula is also responsible for formulating policies and strategic plans intended to identify fertile areas for the ABPM’s continued growth within the House of Medicine.  Previously, Mr. Ondrula was the Strategic Business Affairs & Legal Advisor for the American Board of Medical Specialties (ABMS).  In that role, Mr. Ondrula planned, organized and coordinated projects supporting key ABMS organizational strategic objectives, focusing on ways to improve efficiency.  Mr. Ondrula’s responsibilities at ABMS also included the CertLink Initiative where, among other things, he was chiefly responsible for development of the economic model to assess its viability, as well as his collaborative work with the Ethics and Professional Committee, and strategic efforts in support of the ABMS Legislative Team.  Prior to joining ABMS in 2015, Mr. Ondrula served as the Chief Executive Officer and Director at Heartland Food Corporation which, at the time was the 2nd largest Burger King franchisee in the -World, and, before that he was the Chief Operating Officer and General Counsel for Spence Group Services. Mr. Ondrula received his undergraduate degree in business from Miami University in Oxford, Ohio, and received his Juris Doctorate from Valparaiso University School of Law.  

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of XX AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of XX LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of XX AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn XX Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • Maintaining Fidelity to Evidence-Based Criteria (1.5 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1.5 AMA PRA Category 1 Credit(s)™ while learning about the ASAM Criteria from the 50th Annual Conference (2019).

    (1.5 CME) In this conference recording from the 2019 Annual Conference, you will learn:

    Ongoing efforts to reform the nation’s addiction treatment system often focus on implementation of evidence-based practices. Implementing these practices with fidelity to the evidence-base can present significant challenges. While this culture shift will be difficult, it is necessary to ensure quality of treatment in an environment where quality has sometimes been compromised.  This session will take an in depth look at The ASAM Criteria and the tools that can help support fidelity in implementation including: the CARF ASAM Level of Care Certification program, The ASAM CONTINUUM Software, ASAM Criteria Training Courses, as well as changes to ASAM’s copyright and permissions processes related to The ASAM Criteria. The cost structures and time requirements for these tools and verifications will be discussed, as well as the interaction between the CARF certification and CARF and JCAHO accreditations.  Additionally, opportunities for ASAM members to participate in the educational endeavors and support systems for these endeavors will be listed.





    Paul H. Earley

    MD, DFASAM

    Dr. Earley has worked in Addiction Medicine for over 30 years. He treats all types of addictive disorders and specializes in the assessment, treatment and management of health care professionals. As a therapist, he works with patients already in recovery, providing long term therapy for those who suffer from this disease. His professional expertise extends to advocacy for professionals before agencies and licensing boards. 

    Dr. Earley is a dynamic speaker and educator; he speaks and trains on topics of addiction, its treatment and addiction among health care professionals. In addition, he trains therapists about the neurobiological basis of psychotherapy. In his travels, he has provided training in the United States, Canada, the United Kingdom, Italy, Iceland and Switzerland.

    He is the author of two books and several research articles on addiction and its treatment. His most recent book, RecoveryMind Training is an innovative and comprehensive process designed to reengineer addiction treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) Textbook: Principles of Addiction Medicine, as author of the chapter: Physician Health Programs and Addiction among Physicians. He is a contributing author to the ASAM Criteria. His work was featured in the documentary series on addiction entitled Close to Home by Bill Moyers.

    Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia and the President-elect of the Federation of State Physician Health Programs (FSPHP). Dr. Earley is the current president-elect of the American Society of Addiction Medicine (ASAM). He is a Distinguished Fellow of ASAM and has served on the board of ASAM for over 14 years in several capacities.

    Michael Johnson

    MA, CAP

    Michael W. Johnson, M.A., C.A.P. Michael is currently the Managing Director for Behavioral Health at CARF International, a role he has held since 2013.  In this role, Michael is responsible for the development of standards in behavioral health to maintain currency with the field, interfacing with regulatory entities and payers, consultation and training, and market development. Michael has more than 38 years of experience in the behavioral healthcare field.  He began his career in in behavioral health as a tech on a psychiatric inpatient unit in 1981, and since that time has worked in a variety of clinical, management, and C-level roles in both mental health and substance abuse agencies.  He has been a leader in the industry, providing expertise to national and state initiatives in quality, ethics, training, accreditation, and EMR adoption.  Michael is passionate about the use of data and technology in our industry, and is a tireless advocate for increasing performance in behavioral health.  He possesses a Master of Arts degree in Communications and a Bachelor of Arts degree in Interpersonal Communications from the University of Central Florida, and is a Certified Addictions Professional.

    David R. Gastfriend

    MD, DFASAM

    An addiction psychiatrist, Dr. Gastfriend is Senior Research Scientist at the Public Health Management Corp. At Harvard Medical School, he directed addiction research at Massachusetts General Hospital and was an investigator in the NIDA Cocaine Collaborative Study, NIAAA’s COMBINE Study and NIDA’s Clinical Trials Network. As Vice President at Alkermes, Inc., he directed publications on Vivitrol in clinical, criminal justice and health economics research. His research on the American Society of Addiction Medicine (ASAM) Criteria contributed to endorsement by most U.S. states, and VA/DOD. His 150 scientific publications include The ASAM Criteria and Addiction Treatment Matching. His CONTINUUM – The ASAM Criteria Decision Engine™ and ASAM’s CO-Triage™ assessment tools are being adopted nationwide. He co-founded DynamiCare Health™, a nationally-scalable technology for Contingency Management and predictive analytics, winning Harvard Business School’s new venture global grand prize. He has consulted to the governments of Belgium, China, Iceland, Israel, Norway, Russia and the U.S.

    Margaret Jarvis

    MD, FASAM

    Margaret Jarvis, MD, has been the medical director of Marworth Treatment Facility in Waverly PA since 1999. She is credentialed by ABAM and ABPN in addiction and psychiatry. She has been very involved in work for ASAM and ABAM throughout her career.

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credits towards ABPM MOC Part II requirements.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of AMA PRA Category 1 Credit(s)™ for completing this course.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.